Difference between revisions of "Template:SPCaripiprazoleLA"

Latest revision as of 12:33, 20 February 2025

More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. ^[1]
Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months).

Revision as of 12:22, 20 February 2025 (view source) Casper (talk \| contribs) ← Older edit		Latest revision as of 12:33, 20 February 2025 (view source) Casper (talk \| contribs)
(One intermediate revision by the same user not shown)
Line 1:		Line 1:
	* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref>		* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref>
−	* Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg ~~and 960mg preparations. It is possible to administer~~ a ~~reduced dosage of 300mg~~ and 720mg ~~respectively~~.	+	* Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months).